IMPACT OF SENSOR AUGMENTED PUMP (SAP) IN TYPE 1 DIABETES MELLITUS (DMT1) PATIENTS IN COLOMBIA

被引：0
|
作者：
Lopez Gomez, A. [1 ]
Ichihara, B. [2 ]
Alfonso, R. [3 ]
Arcos, J. [4 ]
Valencia, J. [5 ]
机构：
[1] Medtronic PLC, Bogota, CUN, Colombia
[2] Medtronic, Northridge, CA USA
[3] Random Fdn, Bogota, Colombia
[4] Medtron Colombia, Bogota, Colombia
[5] Medtronic, Miami, FL USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB51
引用
收藏
页码：S117 / S117
页数：1
相关论文
共 50 条
  • [21] Hypoglycemia Reduction in Sensor-Augmented Pump Therapy (SAP) with Predictive Low Glucose Management (SmartGuard™) in Children with Type 1 Diabetes
    Kordonouri, Olga
    Biester, Torben
    Danne, Thomas
    Holder, Martin
    Remus, Kerstin
    Wadien, Tanja
    Dorothee, Kieninger-Baum
    Thomas, Andreas
    DIABETES, 2016, 65 : A223 - A223
  • [22] Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes REPLY
    Bergenstal, Richard M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21): : 2071 - 2071
  • [23] Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
    Bergenstal, Richard M.
    Tamborlane, William V.
    Ahmann, Andrew
    Buse, John B.
    Dailey, George
    Davis, Stephen N.
    Joyce, Carol
    Peoples, Tim
    Perkins, Bruce A.
    Welsh, John B.
    Willi, Steven M.
    Wood, Michael A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (04): : 311 - 320
  • [24] Routine Sensor-Augmented Pump Therapy in Type 1 Diabetes: The INTERPRET Study
    Norgaard, Kirsten
    Scaramuzza, Andrea
    Bratina, Natasa
    Lalic, Nebojsa M.
    Jarosz-Chobot, Przemyslaw
    Kocsis, Gyozo
    Jasinskiene, Edita
    De Block, Christophe
    Carrette, Odile
    Castaneda, Javier
    Cohen, Ohad
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 (04) : 273 - 280
  • [25] Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes
    Jecht, M.
    DIABETOLOGE, 2010, 6 (06): : 486 - 487
  • [26] A PERSPECTIVE OF SENSOR-AUGMENTED INSULIN PUMP THERAPY IN THE TREATMENT OF TYPE 1 DIABETES
    Rayfield, Elliot J.
    ENDOCRINE PRACTICE, 2015, 21 (01) : 91 - 92
  • [27] EFFICACY, SAFETY AND MATERNOFETAL OUTCOMES IN 26 PREGNANT WOMEN WITH TYPE 1 DIABETES MELLITUS IN SENSOR-AUGMENTED PUMP THERAPY
    Gomez Medina, A. M.
    Marin Carrillo, L. F.
    Henao Carrillo, D. C.
    Arevalo Correa, C.
    Silva Herrera, J. L.
    Caceres Mendez, E. A.
    Munoz Velandia, O. M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A107 - A107
  • [28] Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up
    Gomez, Ana M.
    Henao, Diana C.
    Taboada, Lucia B.
    Leguizamon, Guillermo
    Rondon, Martin A.
    Munoz, Oscar M.
    Garcia-Jaramillo, Maira A.
    Leon Vargas, Fabian M.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2625 - 2631
  • [29] PROJECTION OF LONG TERM HEALTH-ECONOMIC BENEFITS OF SENSOR AUGMENTED PUMP (SAP) VERSUS PUMP THERAPY ALONE (CSII) IN TYPE 1 DIABETES, A UK PERSPECTIVE
    Roze, S.
    Cook, M.
    Jethwa, M.
    de Portu, S.
    VALUE IN HEALTH, 2014, 17 (07) : A348 - A348
  • [30] Sensor-Augmented Pump-Based Customized Mathematical Model for Type 1 Diabetes
    Grosman, Benyamin
    Wu, Di
    Miller, Diana
    Lintereur, Louis
    Roy, Anirban
    Parikh, Neha
    Kaufman, Francine R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 (03) : 207 - 221
12345